Zambrano Lozano Rogelio purchased $6.9M of CX (indirect holdings)

Zambrano Lozano Rogelio purchased 400,800 indirectly-held shares of CEMEX SAB DE CV (CX) at $17.28 ($6.93M total) on 2026-09-25.

Original reporting
SEC EDGAR · Zambrano Lozano Rogelio
Published Sep 25, 2026, 10:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 11:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Med
01

Why it matters

The director's sizable buy may be interpreted as a vote of confidence, prompting short-term buying interest.

02

Market read

Insider buying is a classic bullish indicator; traders may consider adding exposure to CMX.

03

What to watch

Potential upcoming regulatory or commodity price changes that may offset the insider's confidence.

Relevance 7/10Novelty 6/10Timing: today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Market effects

Cement and building materials sector may see modest bullish sentiment from insider activity.

Latin American markets could react positively to the signal from a major regional player.

Limited global impact; primarily relevant to investors tracking emerging market industrial stocks.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong conviction signal.

Key entities

  • CEMEX SAB DE CV

    Global building materials company listed on NYSE as CMX.

  • Zambrano Lozano Rogelio

    Director of CEMEX who executed the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CXMedAI 8/10

Cemex Lifts Its 2026 Outlook as EBITDA Jumps 24%

Cemex reported second-quarter operating cash flow of US$1.02 billion, up 24%, as sales rose 12% to about US$4.1 billion, according to the company. Net income increased 9% to around US$347 million. Cemex raised its 2026 EBITDA-growth guidance to 16–17% from a prior high-single-digit outlook.

$CXMed

Cemex Sells Most of Its Colombia Business to Holcim

Cemex S.A.B. de C.V. said it will sell most of its Colombia operations to Holcim for about $485m, including a cement plant, a grinding mill and 20+ concrete/aggregates sites. Cemex expects total proceeds of about $555m, plus ~$70m from other asset sales, while keeping two plants in Colombia.

$CXMed

Cemex Sells Most of Its Colombia Business and Heads North

Cemex said it is divesting most of its Colombia business for about $555 million across several transactions, according to the company. Holcim will buy a cement plant, grinding mill and related assets for $485 million. Cemex expects the exit to close around year-end, subject to regulatory approval, as part of its portfolio rebalancing toward the U.S.

$CXMedAI 8/10

Cemex signs new US$3bn syndicated revolving credit facility

Cemex said it has signed a new five-year US$3bn syndicated revolving credit facility (the 2026 Credit Agreement) to fund general corporate purposes, including refinancing existing obligations for the parent and affiliates. The company said terms keep interest margins and commitments consistent with an investment-grade structure, with a 3.75x leverage cap and 2.75x coverage floor. Pricing is SOFR plus 85–137.5 bps depending on credit rating.